|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Rikshospitalet HF |
|---|---|
| Information provided by: | Rikshospitalet HF |
| ClinicalTrials.gov Identifier: | NCT00278694 |
Purpose
Oxaliplatin and 5FU based preoperative chemoradiation in rectal cancer.
| Condition | Intervention | Phase |
|---|---|---|
|
Rectal Cancer |
Drug: Oxaliplatin and %-FU based preoperative chemoradiation |
Phase II |
| Study Type: | Interventional |
| Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
| Official Title: | Oxaliplatin and 5-FU Based Preoperative Chemoradiation |
| Estimated Enrollment: | 150 |
| Study Start Date: | September 2005 |
| Estimated Study Completion Date: | May 2013 |
Effect of treatment, safety profile and quality of life scorings.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Rectal cancer
Contacts and Locations| Contact: Svein Dueland, MD,PhD | +4722934000 | svein.dueland@radiumhospitalet.no |
| Norway | |
| RRHF | Recruiting |
| Oslo, Norway, 0027 | |
| Contact: Svein Dueland, MD, PhD +4722934000 svein.dueland@radiumhospitalet.no | |
| Study Chair: | Georg Høyer, DH | South region committee for research ethics in Norway |
More Information
| Study ID Numbers: | S-05059, Eudractnr 2005-000024-16 |
| Study First Received: | January 16, 2006 |
| Last Updated: | January 16, 2006 |
| ClinicalTrials.gov Identifier: | NCT00278694 |
| Health Authority: | Norway: Norwegian Medicines Agency |
|
Oxaliplatin, radiation |
|
Digestive System Neoplasms Rectal Neoplasms Gastrointestinal Diseases Intestinal Diseases Rectal Diseases Intestinal Neoplasms Rectal neoplasm |
Oxaliplatin Digestive System Diseases Fluorouracil Gastrointestinal Neoplasms Rectal cancer Colorectal Neoplasms |
|
Neoplasms Neoplasms by Site Antineoplastic Agents Therapeutic Uses Pharmacologic Actions |
